Name | Title | Contact Details |
---|
Hospital Central Services is a Allentown, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
For more than 40 years, Southwest Transplant Alliance (STA) has been saving lives by recovering donated organs for individuals awaiting a life-saving transplant. STA is among the largest of 58 federally designated, non-profit organ procurement organizations. The organization serves communities in 94 counties throughout Texas including North Texas, Beaumont, Bryan/College Station, Corpus Christi, El Paso, Galveston, Midland/Odessa, Temple and Tyler.
Eastern Connecticut Health Network, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Eastern Connecticut Health Network, Inc. is based in Manchester, CT. You can find more information on Eastern Connecticut Health Network, Inc. at www.echn.org
Healthnation, Inc. is a Lisle, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.